Motivational interviews to help maintain abstinence after alcohol withdrawal
IMMANENCE - Intérêt d'un Suivi Sous Forme d'Entretiens Motivationnels spécifiques Post Hospitalisation Sur le Maintien de l'AbstiNENCE Durant l'année Suivant le Sevrage en Alcool
This study tests if using motivational interviews as extra support can help adults who have just gone through alcohol withdrawal stay sober longer compared to regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 104 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Montpellier Academic / other |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT06618755 on ClinicalTrials.gov |
What this trial studies
This clinical study evaluates the effectiveness of reinforced inpatient aftercare, specifically motivational interviewing, compared to usual care for adults with alcohol use disorders following hospital withdrawal. The focus is on increasing the percentage of days of abstinence and reducing relapse rates during the first year post-withdrawal. Participants will receive regular assessments to monitor their abstinence and motivation levels. The study aims to address the high risk of relapse during the consolidation phase after withdrawal, utilizing motivational interviewing as a supportive tool.
Who should consider this trial
Good fit: Ideal candidates are adults with alcohol use disorders who are undergoing inpatient withdrawal and aim for complete abstinence.
Not a fit: Patients who do not understand French or have serious cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve long-term abstinence rates for individuals recovering from alcohol use disorders.
How similar studies have performed: Previous studies have shown that motivational interviewing can be effective in supporting behavior change, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * With alcohol use disorders defined by at least 2 DSM-V criteria for at least 12 months). * Being treated for withdrawal in hospital. * With a goal of complete abstinence. * With a means of communication (telephone). Exclusion Criteria: * Lack of understanding (written and spoken) of the French language. * Breach of HC withdrawal contract, following failure to comply with the rules of the addictology service and somatic complications of addiction. * Eviction from the department, discharge against medical advice during hospitalisation for withdrawal. * Proven cognitive problems compromising understanding of the implications of the study and the proposed follow-up. proposed follow-up. * Serious decompensated somatic pathology. * Non-membership or non-beneficiaries of a national health insurance scheme. * Person protected by law, under guardianship or curatorship. * Not having signed free and informed consent to participate in the research. * Simultaneous participation in another clinical trial.
Where this trial is running
Montpellier
- Thomas RISDORFER DE ISSDENTZI — Montpellier, France (Recruiting)
Study contacts
- Study coordinator: Thomas RISDORFER DE ISSDENTZI
- Email: t-risdorferdeissdentzi@chu-montpellier.fr
- Phone: 04 67 33 70 20
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.